Ancora Advisors’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.7K Hold
381
﹤0.01% 1001
2025
Q4
$66K Buy
381
+244
+178% +$44.4K ﹤0.01% 1049
2025
Q3
$26.1K Hold
137
﹤0.01% 1172
2025
Q2
$24.5K Buy
137
+22
+19% +$3.82K ﹤0.01% 1183
2025
Q1
$19.5K Buy
115
+2
+2% +$329 ﹤0.01% 1202
2024
Q4
$17.1K Hold
113
﹤0.01% 1247
2024
Q3
$17.5K Buy
113
+2
+2% +$299 ﹤0.01% 1223
2024
Q2
$15.2K Hold
111
﹤0.01% 1217
2024
Q1
$14.7K Buy
111
+1
+0.9% +$130 ﹤0.01% 1252
2023
Q4
$15.2K Buy
110
+1
+0.9% +$131 ﹤0.01% 1210
2023
Q3
$13.3K Hold
109
﹤0.01% 1228
2023
Q2
$15.3K Buy
109
+1
+0.9% +$138 ﹤0.01% 1189
2023
Q1
$15.3K Hold
108
﹤0.01% 1189
2022
Q4
$17K Buy
108
+1
+0.9% +$144 ﹤0.01% 1220
2022
Q3
$13K Hold
107
﹤0.01% 1428
2022
Q2
$14K Buy
107
+1
+0.9% +$136 ﹤0.01% 1515
2022
Q1
$15K Hold
106
﹤0.01% 1622
2021
Q4
$18K Buy
106
+1
+1% +$152 ﹤0.01% 1618
2021
Q3
$15K Hold
105
﹤0.01% 1559
2021
Q2
$14K Buy
105
+1
+1% +$131 ﹤0.01% 1441
2021
Q1
$13K Hold
104
﹤0.01% 1391
2020
Q4
$12K Buy
+104
New +$12.7K ﹤0.01% 1159
2018
Q4
Sell
-375
Closed -$40K 748
2018
Q3
$40K Buy
+375
New +$41.1K ﹤0.01% 938
2017
Q1
Sell
-375
Closed -$34K 711
2016
Q4
$34K Buy
+375
New +$32.3K ﹤0.01% 838

Other funds holding DGX

Ancora Advisors's DGX Position: Q1 2026 in Review

Ancora Advisors held its Quest Diagnostics (DGX) position steady in Q1 2026 at 381 shares worth $74.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.

Ancora Advisors first reported a position in DGX in Q4 2016 and has held it in 24 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Ancora Advisors held 381 shares of Quest Diagnostics worth $74.7K as of Q1 2026.
  • Ancora Advisors left its Quest Diagnostics share count unchanged in Q1 2026.
  • Quest Diagnostics made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #1001 holding.
  • Ancora Advisors first reported a position in Quest Diagnostics in Q4 2016 and has held it in 24 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.